The second CR Report of Novartis Hellas follows the GRI G3.1 Guidelines at "B" Application Level, the UN Milennium Goals, the UN Global Compact and the ISO26000 Guidelines.
The first Report in the pharmaceutical industry in Greece at "B" Application Level (checked by GRI)
To open the Report please click on the flag below.
Available in:
